Catalent (NYSE:CTLT) said today that it launched a $400 million underwritten public offering of its common stock.
The Somerset, N.J.-based company plans to give underwriters a 30-day option to buy up to $60 million in additional shares of common stock.
Get the full story at our sister site, Drug Delivery Business News.
The post Catalent launches $400m public offering appeared first on MassDevice.